---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-004908"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2024-02-05T23:59:59+00:00"
generated_at: "2026-06-06T09:08:15.192203+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Panacea Life sells PUR Life assets to related party PLM Holdings for $180K note

## Summary
- PLM Holdings (controlled by Panacea CEO and president) acquires all PUR Life assets and assumes related franchise liabilities.
- Purchase price is a $180,000 promissory note, matching the initial deposit not refunded by PUR Life.
- Prior PUR Life APA rescinded but company retained assets; now sold to related party on Jan. 29, 2024.
- Transaction constitutes a related party transaction under Regulation S-K Item 404.

## SEC filing metadata
- accession: 0001493152-24-004908
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2024-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315224004908/0001493152-24-004908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315224004908/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-004908
- JSON: https://secwatch.observer/filing/0001493152-24-004908.json
- Plain text: https://secwatch.observer/filing/0001493152-24-004908.txt

## Key facts
- Material Agreements
  PANACEA LIFE SCIENCES HOLDINGS, INC. entered into Asset Purchase Agreement with PLM Holdings, Inc. valued at $180,000 promissory note (effective 2024-01-29).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: PLM Holdings, Inc.
  - Value: $180,000 promissory note
  - Effective: 2024-01-29
  source text: On January 29, 2024, Panacea Life Sciences Holdings, Inc., a Nevada corporation (“Panacea” or the “Company”) entered into an asset purchase agreement (the “Purchase Agreement”) with PLM Holdings, Inc., a Colorado corporation (“PLM Holdings”), whereby PLM Holdings acquired from the Company all assets owned by the Company of and relating to the PUR Life Medical System and assumed certain liabilities from the Company relating to the PUR Life Medical System. In compensation to the Company under the Purchase Agreement, PLM Holdings issued to the Company a promissory note for the aggregate purchase price of $180,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1552189/000149315224004908/0001493152-24-004908-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.